SB-223328

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSB-223328
Drug Alias Namecarbapenems (SmithKline)SB-221691SB-213079SB-216271SB-224617 +[7] 
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsMultidrug-Resistant Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSmithkline Beecham Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSmithkline Beecham Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsMultidrug-Resistant Infection

Other Information

ATC CodeN/A
Related LinksN/A